Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...

Despite its leadership in pharmaceutical products for diabetes, Sanofi is not a market leader in blood glucose meters and devices, with firms such as Abbott Diabetes Care and Bayer having a ...

Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

The company provides specialty care, such as DUPIXENT ... medicines for diabetes and cardiovascular diseases; and established ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including World <a target=_blank ...

Vosser covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Molecular ... Nordisk is the leading provider of diabetes-care products in the world.

Sanofi has moved a step closer to getting its new diabetes therapy Zynquista approved in Europe, with a positive opinion from the Committee for Medicinal Products ... to get the care they need ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

It is a beacon of collaboration, compassion, and cutting-edge care.” Dr Alaa Hamed, Global Head of Rare Disease Medical Affairs at Sanofi, reiterated the importance of continued collaboration in ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to improve drug development by speeding up clinical trial recruitment.